Gufic Biosciences Limited (NSE:GUFICBIO)
India flag India · Delayed Price · Currency is INR
384.65
-12.45 (-3.14%)
Aug 1, 2025, 3:29 PM IST

Gufic Biosciences Company Description

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally.

It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals.

The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.

In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products.

It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

Gufic Biosciences Limited
CountryIndia
Founded1970
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,491
CEOPranav Choksi

Contact Details

Address:
S.M. House
Mumbai, Maharashtra 400057
India
Phone91 22 6726 1000
Websitegufic.com

Stock Details

Ticker SymbolGUFICBIO
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE742B01025
SIC Code2834

Key Executives

NamePosition
Pranav Jayesh ChoksiChief Executive Officer and Whole Time Director
Jayesh Pannalal ChoksiChairman and MD
Pankaj Jayakumar GandhiWhole-Time Director
Devkinandan B. RoonghtaChief Financial Officer
Nagesh YarrabathinaChief Operating Officer
Ami Naresh ShahCompany Secretary, Compliance Officer and Legal Manager
Pinak PadhyaAssociate Vice President - Sales and Marketing
Sunil DesaiHead ? Human Resource Department
Ashok Laxman DevPresident of Operation
Shekhar Tarabir AleySenior Vice President - Critical Care SBUs, Nepal and Institution